Literature DB >> 24935874

Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.

Maxwell Greene1, Yongjie Lai1, Nicolle Baella2, Josep Dalmau3, Eric Lancaster1.   

Abstract

IMPORTANCE: The anti-Tr immune response is associated with paraneoplastic cerebellar degeneration and Hodgkin lymphoma (HL). One case series has reported that the Delta/notch-like epidermal growth factor-related receptor (DNER) is the actual target for anti-Tr antibodies, but this result has not been replicated.
OBJECTIVE: To describe a patient with anti-Tr and confirm that DNER is the autoantigen for a series of patients with anti-Tr. DESIGN, SETTING, AND PARTICIPANTS: Observational study and analysis of biological samples for antibodies to DNER at the hospital of the University of Pennsylvania. We examined a cerebrospinal fluid sample from 1 patient with anti-Tr and serum and/or cerebrospinal fluid samples from 5 other patients with anti-Tr. EXPOSURE: Transfection of HEK293T and Hela cells to express DNER coupled to an enhanced green fluorescent protein tag using a plasmid previously used to detect human DNER antibodies.
RESULTS: A man in his 30s with paraneoplastic cerebellar degeneration and anti-Tr underwent treatment with corticosteroids and intravenous immunoglobulin, resulting in clinical improvement before chemotherapy. Despite close oncologic follow-up, a biopsy, positron emission tomography, and computed tomography, he was not diagnosed as having HL until 6 months after symptom onset. The cerebrospinal fluid sample from this patient reacted with cells transfected to express DNER, as did cerebrospinal fluid and/or serum samples from 5 other patients with paraneoplastic cerebellar degeneration, HL, and anti-Tr. Only 4 of the 5 serum samples reacted to permeabilized cells enough to be distinguished from background, but all 5 serum samples convincingly labeled live cells, which had considerably less background. All 6 control serum samples and 1 serum sample from a patient previously diagnosed as having anti-Tr (but without HL or cerebellitis) did not recognize DNER. CONCLUSIONS AND RELEVANCE: This case demonstrates the importance of testing for the anti-Tr immune response in patients with cerebellar degeneration. The strong association of anti-Tr with HL requires careful surveillance for this tumor. We also confirm that DNER is the target antigen of the anti-Tr immune response. Screening for DNER antibodies against living transfected cells may offer an improved signal-to-noise characteristic compared with immunostaining of fixed, permeabilized cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935874      PMCID: PMC4130785          DOI: 10.1001/jamaneurol.2014.999

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  17 in total

1.  Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.

Authors:  F Bernal; S Shams'ili; I Rojas; R Sanchez-Valle; A Saiz; J Dalmau; J Honnorat; P Sillevis Smitt; F Graus
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

2.  Impaired cerebellar functions in mutant mice lacking DNER.

Authors:  Akira Tohgo; Mototsugu Eiraku; Taisuke Miyazaki; Eriko Miura; Shin-Ya Kawaguchi; Miyuki Nishi; Masahiko Watanabe; Tomoo Hirano; Mineko Kengaku; Hiroshi Takeshima
Journal:  Mol Cell Neurosci       Date:  2005-11-17       Impact factor: 4.314

Review 3.  DNER as key molecule for cerebellar maturation.

Authors:  Shin-Ya Saito; Hiroshi Takeshima
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

4.  DNER acts as a neuron-specific Notch ligand during Bergmann glial development.

Authors:  Mototsugu Eiraku; Akira Tohgo; Katsuhiko Ono; Megumi Kaneko; Kazuto Fujishima; Tomoo Hirano; Mineko Kengaku
Journal:  Nat Neurosci       Date:  2005-07       Impact factor: 24.884

5.  Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.

Authors:  Esther de Graaff; Peter Maat; Esther Hulsenboom; Robert van den Berg; Martin van den Bent; Jeroen Demmers; Pieternella J Lugtenburg; Casper C Hoogenraad; Peter Sillevis Smitt
Journal:  Ann Neurol       Date:  2012-03-23       Impact factor: 10.422

6.  Effects of valproic acid in cultured mammalian neurons.

Authors:  J R Buchhalter; M A Dichter
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

7.  Delta/notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons.

Authors:  Mototsugu Eiraku; Yutaka Hirata; Hiroshi Takeshima; Tomoo Hirano; Mineko Kengaku
Journal:  J Biol Chem       Date:  2002-04-11       Impact factor: 5.157

8.  Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease.

Authors:  F Graus; J Dalmau; F Valldeoriola; I Ferrer; R Reñe; C Marin; C J Vecht; T Arbizu; C Targa; J W Moll
Journal:  J Neuroimmunol       Date:  1997-04       Impact factor: 3.478

9.  Cerebellar degeneration with Hodgkin disease. An immunological study.

Authors:  J L Trotter; B A Hendin; C K Osterland
Journal:  Arch Neurol       Date:  1976-09

Review 10.  Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease.

Authors:  J Hammack; H Kotanides; M K Rosenblum; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

View more
  15 in total

Review 1.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

Review 2.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 3.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

Review 4.  Autoantibody Encephalitis: Presentation, Diagnosis, and Management.

Authors:  Eric Lancaster
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

Review 5.  Update on neurological paraneoplastic syndromes.

Authors:  Romana Höftberger; Myrna R Rosenfeld; Josep Dalmau
Journal:  Curr Opin Oncol       Date:  2015-11       Impact factor: 3.645

6.  Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration.

Authors:  Christian Probst; Lars Komorowski; Esther de Graaff; Marleen van Coevorden-Hameete; Veronique Rogemond; Jerome Honnorat; Lidia Sabeter; Francesc Graus; Sven Jarius; Raymond Voltz; Brigitte Wildemann; Diego Franciotta; Inga M Blöcker; Wolfgang Schlumberger; Winfried Stöcker; Peter A E Sillevis Smitt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-02-26

Review 7.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 8.  Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System.

Authors:  Marleen H van Coevorden-Hameete; Maarten J Titulaer; Marco W J Schreurs; Esther de Graaff; Peter A E Sillevis Smitt; Casper C Hoogenraad
Journal:  Front Mol Neurosci       Date:  2016-05-31       Impact factor: 5.639

Review 9.  The Diagnosis and Treatment of Autoimmune Encephalitis.

Authors:  Eric Lancaster
Journal:  J Clin Neurol       Date:  2016-01       Impact factor: 3.077

10.  Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand.

Authors:  Maxwell Greene; Yongjie Lai; Kostandin Pajcini; Will Bailis; Warren S Pear; Eric Lancaster
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.